Document Detail


Resistance to topoisomerase II poisons: is the answer in the promoter?
MedLine Citation:
PMID:  9444936     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
S H Kaufmann
Related Documents :
24682096 - Protection of mice from oral candidiasis by heat-killed enterococcus faecalis, possibly...
15172606 - Resistance form in tooth preparation.
16535446 - Tellurite resistance and reduction by obligately aerobic photosynthetic bacteria.
23467846 - Gliotoxinogenic aspergillus fumigatus in the dairy herd environment.
23476146 - Characterization of yersinia enterocolitica biotype 1a strains isolated from swine slau...
6339336 - Mutagenicity study of nine monoalkyl phthalates and a dialkyl phthalate using salmonell...
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  Leukemia research     Volume:  21     ISSN:  0145-2126     ISO Abbreviation:  Leuk. Res.     Publication Date:    1997 Nov-Dec
Date Detail:
Created Date:  1998-02-10     Completed Date:  1998-02-10     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  7706787     Medline TA:  Leuk Res     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1033-6     Citation Subset:  IM    
Affiliation:
Mayo Clinic and Department of Pharmacology, Mayo Medical School, Rochester, MN 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology*
DNA Damage
DNA Topoisomerases, Type II / antagonists & inhibitors*,  metabolism*
Drug Resistance, Neoplasm
Enzyme Inhibitors / pharmacology*
Humans
Promoter Regions, Genetic / drug effects*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Enzyme Inhibitors; EC 5.99.1.3/DNA Topoisomerases, Type II
Comments/Corrections
Comment On:
Leuk Res. 1997 Aug;21(8):711-20   [PMID:  9379678 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the singl...
Next Document:  Heterogeneity of the inhibitory effects of IL-4 in two novel B lineage acute lymphoblastic leukemia ...